Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rosamaria Roccasecca"'
Autor:
Bruno Bruni Ercole, Riccardo Cortese, Armin Lahm, Anna Tramontano, Rosamaria Roccasecca, Monica Pezzanera, Helenia Ansuini, Alessandra Vitelli, Stefano Acali, Jane A. McKeating, Elisa Scarselli, Asutosh T. Yagnik, Alfredo Nicosia, Annalisa Meola
Publikováno v:
Journal of Virology. 77:1856-1867
The envelope glycoprotein E2 of hepatitis C virus (HCV) is the target of neutralizing antibodies and is presently being evaluated as an HCV vaccine candidate. HCV binds to human cells through the interaction of E2 with the tetraspanin CD81, a putativ
Autor:
Annalisa Meola, Giulia Puntoriero, Rosalba Tafi, Silvia Zucchelli, Antonello Pessi, Alfredo Nicosia, Mario U. Mondelli, Giovanni Galfre, Antonella Folgori, Monica Pezzanera, Riccardo Cortese, Anna Tramontano, Bruno Bruni Ercole, Armin Lahm, Rosamaria Roccasecca
Publikováno v:
International reviews of immunology. 20(2)
Hepatitis C Virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, worldwide, and the development of an effective vaccine represents a high priority goal. The Hyper Variable Region 1 (HVRI) of the second Enve
Autor:
Alfredo Nicosia, Giovanni Galfre, Giulia Puntoriero, Anna Tramontano, Antonella Folgori, Rosalba Tafi, Annalisa Meola, Mario U. Mondelli, Monica Pezzanera, Antonello Pessi, Silvia Zucchelli, Riccardo Cortese, Rosamaria Roccasecca, Armin Lahm, Bruno Bruni Ercole
Publikováno v:
Molecular immunology. 38(6)
Hepatitis C virus (HCV) is a major cause worldwide of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, and the development of an effective vaccine represents a high priority goal. The hyper variable region 1 (HVR1) of the second envel
Autor:
Giovanni Galfre, Riccardo Cortese, Rosalba Tafi, Silvia Zucchelli, Bruno Bruni Ercole, Alfredo Nicosia, Jean Dubuisson, Annalisa Meola, Rosamaria Roccasecca
Publikováno v:
Hepatology (Baltimore, Md.). 33(3)
The hypervariable region 1 (HVR1) of the putative envelope protein E2 of hepatitis C virus (HCV) contains a principal neutralization epitope, and anti-HVR1 antibodies have been shown to possess protective activity in ex vivo neutralization experiment